comparemela.com

Latest Breaking News On - ஐயீநாந் மருந்துகள் இன்க் - Page 3 : comparemela.com

XENE Stock Price, Xenon Pharmaceuticals Stock Quotes and News

XENE Stock Price, Xenon Pharmaceuticals Stock Quotes and News
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Xenon Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals: Q1 Earnings Snapshot by The Associated Press Last Updated May 11, 2021 at 4:28 pm EDT BURNABY, British Columbia (AP) Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $15.8 million in its first quarter. On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 42 cents. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share. The gene therapy biotech company posted revenue of $4.4 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $3.7 million. Xenon Pharmaceuticals shares have climbed 17% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.93, a climb of 39% in the last 12 months.

Xenon Pharmaceuticals: Q1 Earnings Snapshot | iNFOnews | Thompson-Okanagan s News Source

May 11, 2021 - 1:26 PM BURNABY, British Columbia (AP) Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $15.8 million in its first quarter. On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 42 cents. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share. The gene therapy biotech company posted revenue of $4.4 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $3.7 million. Xenon Pharmaceuticals shares have climbed 17% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.93, a climb of 39% in the last 12 months.

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2021 Financial Results and Provide Corporate Update

Article content BURNABY, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its first quarter 2021 financial and operating results after the close of U.S. financial markets on Tuesday, May 11, 2021. Xenon management will host a conference call and live audio webcast on Tuesday, May 11, 2021 at 4:30 pm Eastern Time (1:30 pm Pacific Time) to discuss the first quarter 2021 financial results and provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 1496232.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.